Literature DB >> 9414444

Protein phosphorylation/dephosphorylation in the meiotic cell cycle of mammalian oocytes.

N Dekel1.   

Abstract

The meiotic cell cycle in mammalian oocytes commences in the fetal ovary, proceeds up to the diplotene stage of the first prophase, and is arrested around birth at a G2-like phase. Reinitiation of meiosis, which occurs immediately before ovulation, represents the transition from G2 to M phase of the cell cycle. Resumption of meiosis is associated with a reduction in cAMP concentrations within the oocyte and is negatively regulated by an activated cAMP-dependent protein kinase (PKA). These findings led to the hypothesis that meiotic arrest is mediated by a PKA-phosphoprotein substrate, which undergoes dephosphorylation under conditions of decreasing intra-oocyte concentrations of cAMP. Thus far, a phosphoprotein that serves as a substrate for PKA and maintains meiotic arrest has not been identified. Nevertheless, the idea that regulation of enzyme activities of a series of protein kinases and phosphatases governs the progression through the meiotic cell cycle is now commonly accepted. The present knowledge of the specific phosphorylation/dephosphorylation biochemical events that participate in the control of meiosis in mammalian oocytes is discussed in this review.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9414444     DOI: 10.1530/ror.0.0010082

Source DB:  PubMed          Journal:  Rev Reprod        ISSN: 1359-6004


  14 in total

1.  WEE2 is an oocyte-specific meiosis inhibitor in rhesus macaque monkeys.

Authors:  Carol B Hanna; Shan Yao; Maristela C Patta; Jeffrey T Jensen; Xuemei Wu
Journal:  Biol Reprod       Date:  2010-03-03       Impact factor: 4.285

2.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

3.  Premature ovarian aging in mice deficient for Gpr3.

Authors:  Catherine Ledent; Isabelle Demeestere; David Blum; Julien Petermans; Tuula Hämäläinen; Guillaume Smits; Gilbert Vassart
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-13       Impact factor: 11.205

4.  Mouse Germ Cell Development in-vivo and in-vitro.

Authors:  Deshira Saiti; Orly Lacham-Kaplan
Journal:  Biomark Insights       Date:  2007-06-06

5.  Effects of combined treatment of MG132 and scriptaid on early and term development of porcine somatic cell nuclear transfer embryos.

Authors:  Jiude Mao; Kimberly Tessanne; Kristin M Whitworth; Lee D Spate; Eric M Walters; Melissa S Samuel; Clifton N Murphy; Lisa Tracy; Jianguo Zhao; Randall S Prather
Journal:  Cell Reprogram       Date:  2012-08-23       Impact factor: 1.987

6.  Prediction of secondary ionization of the phosphate group in phosphotyrosine peptides.

Authors:  M Wojciechowski; T Grycuk; J M Antosiewicz; B Lesyng
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

Review 7.  Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation.

Authors:  Minnie Hsieh; A Musa Zamah; Marco Conti
Journal:  Semin Reprod Med       Date:  2009-02-05       Impact factor: 1.303

8.  Fyn and argonaute 2 participate in maternal-mRNA degradation during mouse oocyte maturation.

Authors:  Natalie Gindi; Hadas Grossman; Hadas Bar-Joseph; Irit Miller; Luba Nemerovsky; Ron Hadas; Nava Nevo; Dalia Galiani; Nava Dekel; Ruth Shalgi
Journal:  Cell Cycle       Date:  2022-02-01       Impact factor: 5.173

9.  MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes.

Authors:  John B Mailhes; Colette Hilliard; Mary Lowery; Steve N London
Journal:  Cell Chromosome       Date:  2002-10-08

10.  Okadaic acid, an inhibitor of protein phosphatase 1 and 2A, induces premature separation of sister chromatids during meiosis I and aneuploidy in mouse oocytes in vitro.

Authors:  John B Mailhes; Colette Hilliard; John W Fuseler; Steve N London
Journal:  Chromosome Res       Date:  2003       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.